Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NewGenIvf (NIVF) Receivables (2022 - 2025)

NewGenIvf (NIVF) has disclosed Receivables for 4 consecutive years, with $276784.0 as the latest value for Q4 2025.

  • Quarterly Receivables fell 39.01% to $276784.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $276784.0 through Dec 2025, down 39.01% year-over-year, with the annual reading at $276784.0 for FY2025, 62.05% up from the prior year.
  • Receivables for Q4 2025 was $276784.0 at NewGenIvf, down from $453813.0 in the prior quarter.
  • The five-year high for Receivables was $453813.0 in Q4 2024, with the low at $33728.0 in Q4 2023.
  • Average Receivables over 4 years is $201905.0, with a median of $160039.5 recorded in 2022.
  • The sharpest move saw Receivables surged 1245.51% in 2024, then plummeted 39.01% in 2025.
  • Over 4 years, Receivables stood at $43295.0 in 2022, then fell by 22.1% to $33728.0 in 2023, then soared by 1245.51% to $453813.0 in 2024, then crashed by 39.01% to $276784.0 in 2025.
  • According to Business Quant data, Receivables over the past three periods came in at $276784.0, $453813.0, and $33728.0 for Q4 2025, Q4 2024, and Q4 2023 respectively.